Radionuclide 177Lu-Dotatate Improves QoL in Patients with Neuroendocrine Tumors
MedicalResearch.com,
MedicalResearch.com Interview with: Jonathan Strosberg MD Moffitt Cancer Center, Tampa, FL MedicalResearch.com: What is the…
Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With 177Lu-Dotatate in the Phase III NETTER-1 Trial
Overview of attention for article published in Journal of Clinical Oncology, June 2018
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (97th percentile)
-
High Attention Score compared to outputs of the same age and source (96th percentile)
Mentioned by
- news
- 6 news outlets
- blogs
- 1 blog
- policy
- 1 policy source
- 36 X users
- 1 Facebook page
- wikipedia
- 1 Wikipedia page
- guideline
- 4 clinical guideline sources
Readers on
- mendeley
- 245 Mendeley